Showing results (341-350 of 396) with videos related to
Sort By:
Pageof 40
Cancer|September 2, 2011
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphomaPei Lin, Timothy J Dickason, Luis E Fayad, et al.Trauma Surgery & Acute Care Open|March 1, 2019
Extended resuscitative endovascular balloon occlusion of the aorta (REBOA)-induced type 2 myocardial ischemia: a time-dependent penaltyPhilip J Wasicek, William A Teeter, Shiming Yang, et al.The Journal of Biological Chemistry|May 13, 2005
Reorganization of ErbB family and cell survival signaling after Knock-down of ErbB2 in colon cancer cellsYi Peter Hu, Srinivas Venkateswarlu, Natalia Sergina, et al.Archives of Pathology & Laboratory Medicine|May 6, 2010
Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern ChinaTing Li, L Jeffrey Medeiros, Pei Lin, et al.Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.Circulation|December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsAlexander C Fanaroff, Robert Clare, Karen S Pieper, et al.Advances in Therapy|January 17, 2023
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United StatesMin Huang, Peter A Fasching, Amin Haiderali, et al.The American Journal of Tropical Medicine and Hygiene|October 11, 2017
Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 StudySteven A Silber, Ermias Diro, Netsanet Workneh, et al.Neurocritical Care|September 13, 2023
Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Physiology and Big DataErta Beqiri, Neeraj Badjatia, Ari Ercole, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Development of an observational tool on computer use during roundsDanny Ho, Yan Xiao, Ayan Sen, et al.Pageof 40